Sep 25, 2014

Alkaloid passed the good manufacturing practice inspection from Kazakhstan

The National Expertise Center for medications, medical devices and medical equipment at the Ministry of Health of the Republic of Kazakhstan, following an inspection in the facilities for production of solid pharmaceutical dosage forms and semisynthetic cephalosporins of Alkaloid AD Skopje, carried out in June 2014, issued an approval report for conformity with the principles of Good Manufacturing Practice (GMP).

This is the first inspection of Alkaloid’s pharmaceutical plants carried out by the authorities of member country of the Commonwealth of Independent Countries that is yet another proof for enforcement of the strictest European and international standards that Alkaloid AD Skopje has been practicing on a daily basis, and are foundation for acquiring and maintaining marketing authorizations, that is requirement for placing pharmaceutical products not only in the Republic of Kazakhstan, but in Russia, Belarus and part of other countries in the region.

This approval is yet another confirmation that the application of the most modern production technologies and business standards, as well as the production of safe and efficient high-quality medications, makes the company a worthy competitor on international markets.